ESC 365 - COVID-19 and heart failure: pathophysiology, risk factors, prognostication, and therapeutic strategies - discussion.

HFA Premium Access

COVID-19 and heart failure: pathophysiology, risk factors, prognostication, and therapeutic strategies - discussion.

Session: COVID-19 and heart failure: pathophysiology, risk factors, prognostication, and therapeutic strategies

Topic: Acute Heart Failure

Event: Heart Failure 2022

Congress Presentation

Add to my library

3 more presentations in this session

COVID-19-induced heart failure: pathophysiologic mechanisms, and their relevance to clinical practice.

Speaker: Doctor M. Senni (Bergamo, IT)

Heart failure in COVID-19 patients: prevalence, incidence, and prognostic implications.

Speaker: Doctor S. Liori (Athens, GR)

Screening, detection, and management of heart failure in the COVID-19 pandemic.

Speaker: Doctor M. Pagnesi (Brescia, IT)

Access the full session

COVID-19 and heart failure: pathophysiology, risk factors, prognostication, and therapeutic strategies

Speakers: Doctor M. Senni, Doctor S. Liori, Doctor M. Pagnesi

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources